Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 19,304 | 38,217 | 32,712 | 40,073 | 17,168 |
| Marketable Securities | 15,310 | N/A | 8,478 | 8,475 | N/A |
| Receivables | 205 | 186 | 338 | 435 | 140 |
| TOTAL | $37,497 | $41,112 | $44,365 | $50,743 | $17,733 |
| Non-Current Assets | |||||
| PPE Net | 6 | 5 | 3 | 4 | 13 |
| TOTAL | $6 | $5 | $3 | $4 | $13 |
| Total Assets | $37,503 | $41,117 | $44,368 | $50,747 | $17,745 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,503 | 2,770 | 2,699 | 3,583 | 2,655 |
| TOTAL | $3,503 | $2,770 | $2,699 | $3,583 | $2,655 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,503 | $2,770 | $2,699 | $3,583 | $2,655 |
| Shareholders' Equity | |||||
| Common Shares | 85,546 | 82,512 | 78,134 | 78,131 | 45,632 |
| Retained earnings | -74,667 | -68,846 | -63,238 | -57,097 | -50,940 |
| Other shareholders' equity | 13,805 | 15,906 | 18,426 | 18,230 | 14,729 |
| TOTAL | $34,000 | $38,347 | $41,669 | $47,164 | $15,090 |
| Total Liabilities And Equity | $37,503 | $41,117 | $44,368 | $50,747 | $17,745 |